Journals / Nöropsikiyatri Arşivi / 2019 / Cilt: 56 - Sayı: 3

Obstruktif Uyku Apnesi olan kişilerde tam kan parametrelerinin CPAP tedavisi ile ilişkisi

Response of Blood Parameters to CPAP Treatment in Patients with Obstructive Sleep Apnea

Pages
182–185
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: The NLR and PLR did not change after CPAP treatment in patients with moderate to severe OSA without any comorbidities.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Many studies have evaluated the relationship between the NLR and PLR in patients with obstructive sleep apnea (OSA), and have shown that they are related to inflammation.
📊
Key Findings & Data:We evaluated whether 3 months of continuous positive airway pressure (CPAP) treatment in patients with moderate to severe OSA without any comorbidities would affect the NLR and PLR values.
💡
Conclusion & Impact:Conclusions: The NLR and PLR did not change after CPAP treatment in patients with moderate to severe OSA without any comorbidities.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Many studies have evaluated the relationship between the NLR and PLR in patients with obstructive sleep apnea (OSA), and have shown that they are related to inflammation. We evaluated whether 3 months of continuous positive airway pressure (CPAP) treatment in patients with moderate to severe OSA without any comorbidities would affect the NLR and PLR values. Methods: Full blood count parameters were evaluated before and after 3 months of CPAP treatment in patients with a diagnosis of moderate to severe OSA without any comorbidities. Results: Twenty-nine patients (18 [62.1%] males) were enrolled. The mean body mass index (BMI) was 34.85±5.75 kg/m2, the apneahypopnea index score was 49.85±27.42, and CPAP was 9.34±1.77. No significant change in BMI was observed after the third month of treatment. Although the Epworth Sleepiness Scale (ESS) score decreased significantly (p=0.000), no changes were observed in the NLR, PLR, or C-reactive protein level (p>0.05). Mean platelet volume and red blood cell distribution width changed significantly after treatment (p=0.01; p<0.001). Conclusions: The NLR and PLR did not change after CPAP treatment in patients with moderate to severe OSA without any comorbidities.

Özet

Introduction: Many studies have evaluated the relationship between the NLR and PLR in patients with obstructive sleep apnea (OSA), and have shown that they are related to inflammation. We evaluated whether 3 months of continuous positive airway pressure (CPAP) treatment in patients with moderate to severe OSA without any comorbidities would affect the NLR and PLR values. Methods: Full blood count parameters were evaluated before and after 3 months of CPAP treatment in patients with a diagnosis of moderate to severe OSA without any comorbidities. Results: Twenty-nine patients (18 [62.1%] males) were enrolled. The mean body mass index (BMI) was 34.85±5.75 kg/m2, the apneahypopnea index score was 49.85±27.42, and CPAP was 9.34±1.77. No significant change in BMI was observed after the third month of treatment. Although the Epworth Sleepiness Scale (ESS) score decreased significantly (p=0.000), no changes were observed in the NLR, PLR, or C-reactive protein level (p>0.05). Mean platelet volume and red blood cell distribution width changed significantly after treatment (p=0.01; p<0.001). Conclusions: The NLR and PLR did not change after CPAP treatment in patients with moderate to severe OSA without any comorbidities.

🔖

Cite This Article

ÖZDEMİR, C., SÖKÜCÜ, S., AYDIN, Ş., ÖNÜR, S. T., KARA, K. (2019). Obstruktif Uyku Apnesi olan kişilerde tam kan parametrelerinin CPAP tedavisi ile ilişkisi. Nöropsikiyatri Arşivi, Cilt: 56 - Sayı: 3, 182–185. https://ajindex.com/articles/294433

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G, Meghani M, Akhtar M, Costantino T. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther 2013
  2. 55–59. [CrossRef] 2. Proctor MJ, McMillan DC, Morrison DS, Fletcher CD, Horgan PG, Clarke SJ. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer 2012
  3. 695–699. [CrossRef] 3. Faria SS, Fernandes PC Jr, Silva MJ, Lima VC, Fontes W, Freitas-Junior R, Eterovic AK, Forget P. The neutrophil-to-lymphocyte ratio: a narrative review. Ecancermedicalscience 2016
  4. [CrossRef] 4. Korkmaz M, Korkmaz H, Küçüker F, Ayyıldız SN, Çankaya S. Evaluation of the association of sleep apnea-related systemic inflammation with CRP, ESR, and neutrophil-to-lymphocyte ratio. Med Sci Monit 2015
  5. 477–481. [CrossRef] 5. Cingoz F, Iyisoy A, Demirkol S, Sahin MA, Balta S, Celik T, Unlu M, Arslan Z, Cakar M, Kucuk U, Demirbas S, Kocak N. Carotid intima-media thickness in patients with slow coronary flow and its association with neutrophil-to-lymphocyte ratio: a preliminary report. Clin Appl Thromb Hemost 2014
  6. 393– 399. [CrossRef] 6. Koseoglu S, Ozcan KM, Ikinciogullari A, Cetin MA, Yildirim E, Dere H. Relationship Between Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio and Obstructive Sleep Apnea Syndrome. Adv Clin Exp Med 2015
  7. 623–627. [CrossRef] 7. Uygur F, Tanriverdi H, Aktop Z, Erboy F, Altinsoy B, Damar M, Atalay F. The neutrophil-to-lymphocyte ratio in patients with obstructive sleep apnoea syndrome and its relationship with cardiovascular disease. Heart Lung 2016
  8. 121–125. [CrossRef] 8. Faraut B, Boudjeltia KZ, Vanhamme L, Kerkhofs M. Immune, inflammatory and cardiovascular consequences of sleep restriction and recovery. Sleep Med Rev 2012
  9. 137–149. [CrossRef] 9. Simpson N, Dinges DF. Sleep and inflammation. Nutr Rev 2007
  10. 244–252. 10. Conwell W, Lee-Chiong T Jr. Sleep apnea, chronic sleep restriction, and inflammation. Perioperative implications. Sleep Med Clin 2013
  11. 11–21. [CrossRef] 11. Panoutsopoulos A, Kallianos A, Kostopoulos K, Seretis C, Koufogiorga E, Protogerou A, Trakada G, Kostopoulos C, Zakopoulos N, Nikolopoulos I. Effect of CPAP treatment on endothelial function and plasma CRP levels in patients with sleep apnea. Med Sci Monit 2012
  12. CR747–751. 12. Baessler A, Nadeem R, Harvey M, Madbouly E, Younus A, Sajid H, Naseem J, Asif A, Bawaadam H. Treatment for sleep apnea by continuous positive airway